The molecular biology of serotonin receptors: Therapeutic implications for the interface of mood and psychosis

Biological Psychiatry

Volumn 44, Issue 11, 1998, Pages 1128-1142

  Kroeze, Wesley K ^a   Roth, Bryan L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug design; Psychosis; Schizophrenia; Serotonin; Serotonin receptors; Serotonin(2A)

Indexed keywords

RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR;

AMINO ACID SEQUENCE; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR AFFINITY; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLONING, MOLECULAR; HUMANS; MOOD DISORDERS; PSYCHOTIC DISORDERS; RECEPTORS, SEROTONIN;

EID: 0032402417     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00132-2     Document Type: Review

References (157)

1. 1F receptors for β-adrenergic antagonists. Neuropharmacology. 33:1994;387-391.
2. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
3. Albert P.R., Lembo P., Storring J.M., Charest A., Saucier C. The 5-HT1A receptor Signaling, desensitization, and gene transcription . Neuropsychopharmacology. 14:1996;19-25.
4. 2C receptors Direct and indirect effects on ligand affinity mediated by the same locus . Mol Pharmacol. 50:1996;34-42.
5. 2A receptor. J Biol Chem. 271:1996;14672-14675.
6. Altar C.A., Boyer W.C., Wasley A., Liebman J.M., Wood P.L., Gerhardt S.G. Dopamine neurochemical profile of atypical antipsychotics resemble that of D-1 antagonists. Naunyn Schmiedebergs Arch Pharmacol. 338:1988;162-168.
7. Angst J., Stassen H.H., Woggon B. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology (Berl). 99:(suppl):1989;S41-S46.
8. Araneda R., Andrade R. 5-hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
9. Arthur J.M., Collinsworth G.P., Gettys T.W., Quarles L.D., Raymond J.R. Specific coupling of a cation-sensing receptor to G protein alpha-subunits in MDCK cells. Am J Physiol. 273:1997;F129-F135.
10. Baldwin J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1993;1693-1703.
11. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol. 6:1994;180-190.
12. Barak L.S., Ferguson S.S., Zhang J., Martenson C., Meyer T., Caron M.G. Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol Pharmacol. 51:1997;177-184.
13. 7) positively linked to adenylate cyclase. J Biol Chem. 268:1993;23422-23426.
14. Benes F.M. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry. 52:1995;1015-1018.
15. Berry S.A., Shah M.C., Khan N., Roth B.L. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol Pharmacol. 50:1996;306-313.
16. 1C serotonin receptor gene. Mol Brain Res. 17:1993;194-200.
17. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
18. Branchek T., Mawe G., Gershon M.D. Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype with a selective agonist, 3H-5-hydroxyindalpine. J Neurosci. 8:1988;2582-2595.
19. Burnet P.W., Michelson D., Smith M.A., Gold P.W., Sternberg E.M. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638:1994;311-324.
20. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 387:1997;303-308.
21. 2C receptor produced by alternative splicing. Mol Pharmacol. 50:1996;799-807.
22. Chalmers D.T., Lopez J.F., Vazquez D.M., Akil H., Watson S.J. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 10:1994;215-222.
23. 1A serotonin receptor. Mol Pharmacol. 43:1993;516-520.
24. 2 receptor is encoded by a multiple intron-exon gene. Mol Brain Res. 14:1992;20-26.
25. Chen Y., Peng L., Zhang X., Stolzenburg J.U., Hertz L. Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells. Brain Res Bull. 38:1995;153-159.
26. 2B receptor Homologous subtype or species variant? Behav Brain Res. 73:1996;253-257.
27. 2 receptors. Mol Pharmacol. 43:1993;755-761.
28. 2A receptors Ergolines require an aromatic residue at position 340 for high affinity binding . Mol Pharmacol. 47:1995;450-457.
29. Chuprun J.K., Raymond J.R., Blackshear P.J. The heterotrimeric G protein G alpha i2 mediates lysophosphatidic acid-stimulated induction of the c-fos gene in mouse fibroblasts. J Biol Chem. 272:1997;773-781.
30. 4L receptor. FEBS Lett. 398:1996;19-25.
31. 2A/2C receptor systems. Soc Neurosci Abs. 23:1997;1686.
32. Conn P.J., Sanders-Bush E. Selective 5-HT2 antagonists inhibit serotonin-stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology. 23:1984;993-996.
33. 2A receptor . J Neurochem. 63:1994;465-469.
34. 3 receptors are membrane ion channels. Nature. 339:1989;706-709.
35. Ding D., Toth M., Zhou Y., Parks C., Hoffman B.J., Chenk T. Glial cell-specific expression of the serotonin 2 receptor gene Selective reactivation of a repressed promoter . Mol Brain Res. 20:1993;181-191.
36. Du Y.L., Wilcox B.D., Teitler M., Jeffrey J.J. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter Constitutive and inducible activity in myometrial smooth muscle cells . Mol Pharmacol. 45:1994;1125-1131.
37. Du Y.L., Wilcox B.D., Jeffrey J.J. Regulation of rat 5-hydroxytryptamine type 2 receptor gene activity Identification of cis elements that mediate basal and 5-hydroxytryptamine-dependent gene activation . Mol Pharmacol. 47:1995;915-922.
38. Edvardsen O, Kristiansen K (1997): Computerization of mutant data: The tinyGRAP mutant database. 7TM J 6:1-6.
39. 1A receptor. Nature. 335:1988;358-360.
40. Ferguson S.S., Barak L.S., Zhang J., Caron M.G. G-protein-coupled receptor regulation Role of G-protein-coupled receptor kinases and arrestins . Can J Physiol Pharmacol. 74:1996;1095-1110.
41. Fischer-Cornelssen K.A. Fluperlapine in 104 schizophrenic patients. Open multicenter trial. Arzneimittelforschung. 34:1984;125-130.
42. Fleischhacker W.W., Stuppack C., Moser C., Schubert H., Hinterhuber H. Fluperlapine vs haloperidol A comparison of their neuroendocrinological profiles and the influence on serum lipids . Pharmacopsychiatry. 19:1986;111-114.
43. Garlow S.J., Ciaranello R.D. Transcriptional control of the rat serotonin-2 receptor gene. Mol Brain Res. 31:1995;201-209.
44. Garlow S.J., Chin A.C., Marinovitch M.A., Heller M.R., Ciaranello R.D. Cloning and functional promoter mapping of the rat serotonin-2 receptor gene. Mol Cell Neurosci. 5:1994;291-300.
45. Garnovskaya M.N., Nebigil C.G., Arthur J.M., Spurney R.F., Raymond J.R. 5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation. Mol Pharmacol. 48:1995;230-237.
46. Garnovskaya M.N., van Biesen T., Hawe B., Casanas Ramos S., Lefkowitz R.J., Raymond J.R. Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway. Biochemistry. 35:1996;13716-13722.
47. Garnovskaya M.N., Gettys T.W., van Biesen T., Prpic V., Chuprun J.K., Raymond J.R. 5-HT1A receptor activates Na+/H+ exchange in CHO-K1 cells through Gialpha2 and Gialpha3. J Biol Chem. 272:1997;7770-7776.
48. 4 receptor Molecular cloning and pharmacological characterization of two splice variants . EMBO J. 14:1995;2806-2815.
49. Gettys T.W., Fields T.A., Raymond J.R. Selective activation of inhibitory G-protein alpha-subunits by partial agonists of the human 5-HT1A receptor. Biochemistry. 33:1994;4283-4290.
50. 1Dβ T355N mutant receptors may involve formation of two hydrogen bonds to asparagine. Mol Pharmacol. 49:1996;198-206.
51. Goodman O., Krupnick J., Santini F., Gurevich V.V., Penn R.B., Gagnon A.W., et al. β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature. 383:1996;447-450.
52. 1A receptors. Mol Pharmacol. 41:1992;695-698.
53. Gudelsky G.A., Koenig J.I., Simonovic M., Koyama T., Ohmori T., Meltzer H.Y. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. J Neural Transm. 68:1987;227-240.
54. Guillet-Deniau I., Burnol A.F., Girard J. Identification and localization of a skeletal muscle serotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J Biol Chem. 272:1997;14825-14829.
55. Hartig P.R. Molecular biology and transductional characteristics of 5-HT receptors. Baumgarten H.G., Gothert M. Serotonergic Neurons and 5-HT Receptors in the CNS (Handbook of Experimental Pharmacology vol 129). 1997;175-212 Springer-Verlag, Berlin.
56. 1Dβ receptors. FEBS Lett. 377:1995;73-76.
57. 7) receptor isoforms in human and rat produced by alternative splicing Species differences due to altered intron-exon organization . J Neurochem. 68:1997;1372-1381.
58. Higgins D.G., Sharp P.M. CLUSTAL A package for performing multiple sequence alignment on a microcomputer . Gene. 73:1988;237-244.
59. 1A receptor A site-directed mutation study . FEBS Lett. 312:1992;259-262.
60. Houghten R.A. Combinatorial libraries. Finding the needle in the haystack. Curr Biol. 4:1994;564-567.
61. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:1994;157-203.
62. Joffe H., Cohen L.S. Estrogen, serotonin and mood disturbance Where is the therapeutic bridge? Biol Psychiatry. 44:1998;798-811.
63. Johnson M.P., Loncharich R.J., Baez M., Nelson D.L. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol Pharmacol. 45:1994;277-286.
64. 2A receptors reveal conserved transmembrane homology to the human rather than rat sequence . Biochim Biophys Acta. 1236:1995;201-206.
65. Julius D., MacDermott A.B., Axel R., Jessel T. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science. 241:1988;558-564.
66. 2 receptor from a human to a rat pharmacology. FEBS Lett. 307:1992;324-328.
67. Kawahara H., Isoai A., Shizuri Y. Molecular cloning of a putative serotonin receptor gene from barnacle, Balanus amphitrite. Gene. 184:1997;245-250.
68. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 329:1987;75-79.
69. 6 receptor. J Neurochem. 66:1996;47-56.
70. Korsgaard S., Noring U., Gerlach J. Fluperlapine in tardive dyskinesia and parkinsonism. Psychopharmacology (Berl). 84:1984;76-79.
71. Kristiansen K., Dahl S.G. Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions. Eur J Pharmacol. 306:1996;195-210.
72. Kristiansen K., Edvardsen O., Dahl S. Molecular modeling of ketanserin and its interactions with the 5-HT2 receptor. Med Chem Res. 3:1993;370-385.
73. Kristiansen K, Dahl SG, Edvardsen O (1996): A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptors. Proteins: Structure, Function and Genetics 26:81-94 (Internet address; http://www-grap.fagmed.uit.no/GRAP/homepage.html).
74. 2B receptor. Mol Pharmacol. 46:1994;227-234.
75. Launay J.M., Birraux G., Bondoux D., Callebert J., Choi D.S., Loric D.S., et al. Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem. 271:1996;3141-3147.
76. Le Corre S., Sharp T., Young A.H., Harrison P.J. Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy. Psychopharmacology (Berl). 130:1997;368-374.
77. Li X.C., Giot J.F., Kuhl D., Hen R., Kandel E.R. Cloning and characterization of two related serotonergic receptors from the brain and reproductive system of Aplysia that activate phospholipase C. J Neurosci. 15:1995;7585-7591.
78. Liebowitz S., Alexander J. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry. 44:1998;851-864.
79. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry. 44:1998;151-162.
80. Maes M, Meltzer HY (1995): The role of serotonin in depression. In: Bloom FE, Kupfer DG, editors. Psychopharmacology: A Fourth Generation of Progress. New York: Raven Press, pp.
81. Mangel A.W., Raymond J.R., Fitz J.G. Regulation of high-conductance anion channels by G proteins and 5-HT1A receptors in CHO cells. Am J Physiol. 264:1993;F490-F495.
82. Mann K., Bartels M., Gartner H.J., Schied H.W., Wagner W., Heimann H. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study. Pharmacopsychiatry. 20:1987;155-159.
83. Marek GJ, Aghajanian G (1998): The electrophysiology of prefrontal serotonin systems: Therapeutic implications for mood and psychosis. Biol Psychiatry (current issue).
84. 5B receptors define a new family of serotonin receptors Cloning, functional expression, and chromosomal location . Mol Pharmacol. 43:1993;313-319.
85. Mayer S.E., Sanders-Bush E. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport. Mol Pharmacol. 45:1994;991-996.
86. Meltzer H.Y. Clozapine Clinical advantages and biological mechanisms . Schulz S.C., Tamminga C. Schizophrenia A Scientific Focus . 1989;302-309 Oxford University Press, New York.
87. Meltzer H.Y., Matsubara S., Lee J.-C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther. 251:1989;238-246.
88. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology. 55:1992;444-450.
89. 355Asn site directed mutagenesis. Biochem Pharmacol. 44:1992;1917-1920.
90. Middleton J.P., Raymond J.R., Whorton A.R., Dennis V.W. Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant human serotonin 5-HT1A receptor expressed in HeLa cells. J Clin Invest. 86:1990;1799-1805.
91. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol. 43:1993;320-327.
92. Mulheron J.G., Casanas S.J., Arthur J.M., Garnovskaya M.N., Gettys T.W., Raymond J.R. Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem. 269:1994;12954-12962.
93. Nelson C.S., Cone R.D., Robbins L.S., Allen C.N., Adelman J.P. Cloning and expression of a 5HT7 receptor from Xenopus laevis. Receptors Channels. 3:1995;61-70.
94. 1B receptors. Nature. 360:1992;161-163.
95. Olde B., McCombie W.R. Molecular cloning and functional expression of a serotonin receptor from Caenorhabditis elegans. J Mol Neurosci. 8:1997;53-62.
96. Pakkenberg H., Pedersen B. Medical treatment of dystonia. Psychopharmacology (Berl). (suppl 2):1985;111-117.
97. 2C receptor. Psychopharmacology (Berl). 126:1996;234-240.
98. 1B receptors. J Neurochem. 60:1993;380-383.
99. 1E receptors. J Neurochem. 67:1996;2096-2103.
100. Parks C.L., Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem. 271:1996;4417-4430.
101. Parks C.L., Chang L.S., Shenk T. A polymerase chain reaction mediated by a single primer Cloning of genomic sequences adjacent to a serotonin receptor protein coding region . Nucl Acids Res. 19:1991;7155-7160.
102. Peroutka S.J. Molecular biology of serotonin (5-HT) receptors. Synapse. 18:1994;241-260.
103. Peroutka S.J., Howell T.A. The molecular evolution of G protein-coupled receptors Focus on 5-hydroxytryptamine receptors . Neuropharmacology. 33:1994;319-324.
104. Plassat J.L., Amlaiky N., Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol Pharmacol. 44:1993;229-236.
105. 2 receptor. EMBO J. 7:1988;4135-4140.
106. Raymond J.R. Multiple mechanisms of receptor-G protein signaling specificity. Am J Physiol. 269:1995;F141-F158.
107. Raymond J.R., Albers F.J., Middleton J.P. Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 346:1992;127-137.
108. Raymond J.R., Olsen C.L., Gettys T.W. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry. 32:1993;11064-11073.
109. 5A receptor. FEBS Lett. 355:1994;242-246.
110. Roth B.L. Multiple serotonin receptors Clinical and experimental aspects . Ann Clin Psychiatry. 6:1994;67-78.
111. Roth B.L., Chuang D.M. Multiple mechanisms of serotonergic signal transduction. Life Sci. 41:1987;1051-1064.
112. Roth B.L., Hyde E.G. Pharmacology of 5-HT2 receptors. Baumgarten H.G., Gothert M. Serotonergic Neurons and 5-HT Receptors in the CNS (Handbook of Experimental Pharmacology vol 129). 1997;367-394 Springer-Verlag, Berlin.
113. Roth B.L., Meltzer H.Y. The role of serotonin in schizophrenia. Bloom F.E., Kupfer D.G. Psychopharmacology A Fourth Generation of Progress . 1995;1215-1227 Raven Press, New York.
114. Roth B.L., Nakaki T., Chuang D.M., Costa E. Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology. 23:1984;1223-1225.
115. 1C serotonin receptor levels Methodology and mechanisms . Neuropsychopharmacology. 3:1990;427-433.
116. 1C mRNA and receptor levels. Dev Brain Res. 58:1991;51-58.
117. 1C receptors. J Pharmacol Exp Ther. 260:1992;1361-1365.
118. Roth B.L., Choudhary M.S., Craigo S. Mutagenesis of 5-HT2 serotonin receptors What does an analysis of many mutant receptors tell us? Med Chem Res. 3:1993;297-305.
119. Roth B.L., Craigo S.C., Choudhary S., Uluer A., Monsma F.J., Shen Y., et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 268:1994;1403-1410.
120. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology (Berl). 120:1995;365-368.
121. 2a receptors. Mol Pharmacol. 52:1997;259-266.
122. Roth B.L., Meltzer H.Y., Khan N. Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors. Adv Pharmacol. 42:1998;482-485.
123. 2C): Where structure meets function. Pharmacol Ther.
124. Roth BL, Willins DL, Kroeze WK (in press b): G-protein coupled receptor (GPCR) trafficking in the central nervous system: Relevance for drugs of abuse. Drug Alcohol Depend.
125. 6) receptor Molecular cloning, localization and stimulation of cAMP accumulation . Biochem Biophys Res Commun. 193:1993;268-276.
126. 7) activating cAMP formation. Proc Natl Acad Sci USA. 90:1993;8547-8551.
127. Saitoh O., Yuruzume E., Watanabe K., Nakata H. Molecular identification of a G protein-coupled receptor family which is expressed in planarians. Gene. 195:1997;55-61.
128. Saudou F., Boschert U., Amlaiky N., Plassat J.L., Hen R. A family of Drosophila serotonin receptors with distinct intracellular signalling properties and expression patterns. EMBO J. 11:1992;1-7.
129. Schertler G., Hargrave P. Projection structure of frog rhodopsin in two crystal forms. Proc Natl Acad Sci USA. 92:1995;11578-11582.
130. 2B serotonin receptor. FEBS Lett. 342:1994;85-90.
131. Scholz E., Dichgans J. Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. Eur Arch Psychiatry Neurol Sci. 235:1985;60-64.
132. 2A receptor. J Biol Chem. 270:1995;16683-16688.
133. 7 serotonin receptor subtype. J Biol Chem. 268:1993;18200-18204.
134. 1A receptor genes. Eur J Pharmacol. 227:1992;153-162.
135. 2C receptor. Eur J Pharmacol. 269:1994;339-348.
136. Tecott L.H., Sun L., Julius D. Chimeric mice with targeted disruptions of the 5-HT1c receptor gene. Soc Neurosci Abs. 19:1993;632.
137. Teitler M., Herrick-Davis K. Multiple serotonin receptor subtypes Molecular cloning and functional expression . Crit Rev Neurobiol. 8:1994;175-188.
138. Toth M., Shenk T. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression Modulation of transcription . Mol Pharmacol. 45:1994;1095-1100.
139. Toth M., Ding D., Shenk T. The 5′ flanking region of the serotonin 2 receptor gene directs brain specific expression in transgenic animals. Mol Brain Res. 27:1994;315-319.
140. 7 receptor positively coupled to adenylyl cyclase. J Neurochem. 63:1994;456-464.
141. von Nickisch-Rosenegk E., Krieger J., Kubick S., Laage R., Strobel J., Strotmann J., et al. Cloning of biogenic amine receptors from moths (Bombyx mori and Heliothis virescens). Insect Biochem Mol Biol. 26:1996;817-827.
142. Wang C.D., Gallaher T.K., Shih J.C. Site-directed mutagenesis of the serotonin 5-hydroxytryptamine receptor Identification of amino acids necessary for ligand binding and receptor activation . Mol Pharmacol. 43:1993;931-940.
143. Weinstein H, Zhang D (1995): Receptor models and ligand-induced responses: New insights for structure-activity relations. In: Sanz F, Giraldo J, Manaut F, editors. QSAR and Molecular Modelling: Concepts, Prous Science Publishers, pp 497-507.
144. Westkaemper R., Glennon R. Molecular graphics models of members of 5-HT2 subfamily 5-HT2A, 5-HT2B, and 5-HT2C receptors . Med Chem Res. 3:1993;317-334.
145. 2A binding pocket allows for enhanced affinities for ketanserin analogs.
146. Willins D.L., Alsayegh L., Berry S., Khan N., Roth B.L. The atypical antipsychotic drug clozapine alters the subcellular distribution of 5-HT2A receptors. Soc Neurosci Abs. 23:1997;972.
147. Willins D.L., Deutch A.Y., Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27:1997;79-82.
148. Woggon B., Angst J., Bartels M., Heinrich K., Hippins H., Koukkou M., et al. Antipsychotic efficacy of fluperlapine. An open multicenter trial. Neuropsychobiology. 11:1984;116-120.
149. Woggon B., Heinrich K., Kufferle B., Muller-Oerlinghausen B., Poldinger W., Ruther E., et al. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients. Arzneimittelforschung. 34:1984;122-124.
150. 2C receptor Complete cDNA, genomic structure, and alternatively spliced variant . Genomics. 35:1996;551-561.
151. Yamaguchi F., Brenner S. Molecular cloning of 5-hydroxytryptamine (5-HT) type 1 receptor genes from the Japanese puffer fish, Fugu rubripes. Gene. 191:1997;219-223.
152. Yang W., Chen F., Lan N.C., Gallaher T.K., Shih J.C. Gene structure and expression of the mouse 5-HT2 receptor. J Neurosci Res. 33:1992;196-204.
153. Yau J.L., Noble J., Widdowson J., Seckl J.R. Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Brain Res Mol Brain Res. 45:1997;182-186.
154. Zeng X.P., Le F., Richelson E. Muscarinic m4 receptor activation by some atypical antipsychotic drugs. Eur J Pharmacol. 321:1997;349-354.
155. Zhong P., Ciaranello R.D. Transcriptional regulation of hippocampal 5-HT1a receptors by corticosteroid hormones. Brain Res Mol Brain Res. 29:1995;23-34.
156. 2A receptor gene promoter. J Neurosci. 15:1995;4885-4895.
157. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev. 44:1992;401-458.